FT Options
Latest statistics and disclosures from FT Options's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INCY, GILD, Clovis Oncology, IBB, INSM, and represent 35.42% of FT Options's stock portfolio.
- Added to shares of these 10 stocks: GILD (+$14M), INCY (+$8.8M), INSM (+$5.9M), ABBV (+$5.8M), Dbv Technologies S A (+$5.4M), Zogenix, Time Warner, Aimmune Therapeutics, ALNY, NKE.
- Started 47 new stock positions in HSIC, Juno Therapeutics, Dermira, PLCE, Loxo Oncology, CYTK, EXAS, TEVA, United Technologies Corporation, HLF.
- Reduced shares in these 10 stocks: Portola Pharmaceuticals (-$12M), Clovis Oncology (-$7.9M), GIS (-$6.2M), AMGN (-$5.5M), CLX (-$5.4M), , K, , IBB, REGN.
- Sold out of its positions in AK Steel Holding Corporation, A, AMGN, Bank of the Ozarks, BCRX, BKD, CPB, Celgene Corporation, STZ, COST.
- FT Options was a net seller of stock by $-1.6M.
- FT Options has $184M in assets under management (AUM), dropping by -10.35%.
- Central Index Key (CIK): 0001594954
Portfolio Holdings for FT Options
FT Options holds 112 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 7.6 | $14M | +167% | 120k | 116.76 |
|
| Gilead Sciences (GILD) | 7.6 | $14M | NEW | 172k | 80.99 |
|
| Clovis Oncology | 7.0 | $13M | -38% | 156k | 82.39 |
|
| iShares NASDAQ Biotechnology Index (IBB) | 6.7 | $12M | -16% | 37k | 333.70 |
|
| Insmed (INSM) | 6.5 | $12M | +97% | 386k | 31.19 |
|
| Gw Pharmaceuticals Plc ads | 6.5 | $12M | +21% | 117k | 101.50 |
|
| Tesaro | 5.1 | $9.3M | +8% | 72k | 129.10 |
|
| Time Warner | 5.0 | $9.2M | +48% | 90k | 102.40 |
|
| Abbvie (ABBV) | 4.1 | $7.6M | +327% | 85k | 88.84 |
|
| General Mills (GIS) | 3.3 | $6.1M | -50% | 119k | 51.80 |
|
| Regeneron Pharmaceuticals (REGN) | 3.2 | $5.9M | -28% | 13k | 447.20 |
|
| Dbv Technologies S A | 3.0 | $5.4M | NEW | 128k | 42.43 |
|
| Kimberly-Clark Corporation (KMB) | 2.8 | $5.2M | +38% | 44k | 117.63 |
|
| Zogenix | 2.5 | $4.6M | NEW | 130k | 35.07 |
|
| Clorox Company (CLX) | 2.1 | $3.9M | -57% | 30k | 132.08 |
|
| Sage Therapeutics (SAGE) | 2.1 | $3.9M | -24% | 64k | 62.23 |
|
| Alibaba Group Holding (BABA) | 1.9 | $3.4M | 20k | 172.73 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $2.9M | +509% | 140k | 20.78 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.5 | $2.7M | +13% | 112k | 24.27 |
|
| Aimmune Therapeutics | 1.5 | $2.7M | NEW | 109k | 24.81 |
|
| Nike (NKE) | 1.1 | $2.1M | NEW | 41k | 51.86 |
|
| DaVita (DVA) | 1.1 | $2.0M | -28% | 35k | 59.37 |
|
| Ptc Therapeutics I (PTCT) | 1.0 | $1.9M | NEW | 92k | 20.04 |
|
| Akebia Therapeutics (AKBA) | 0.9 | $1.7M | +45% | 220k | 7.62 |
|
| La Jolla Pharmaceuticl Com Par | 0.9 | $1.6M | NEW | 45k | 34.87 |
|
| Bristol Myers Squibb (BMY) | 0.8 | $1.5M | +104% | 177k | 8.73 |
|
| Intercept Pharmaceuticals In | 0.8 | $1.5M | NEW | 111k | 13.55 |
|
| Kraft Heinz (KHC) | 0.8 | $1.5M | -59% | 19k | 77.50 |
|
| Kite Pharma | 0.8 | $1.5M | +348% | 114k | 12.84 |
|
| Restaurant Brands Intl Inc Com equity / large cap (QSR) | 0.6 | $1.1M | NEW | 18k | 63.92 |
|
| Aerie Pharmaceuticals | 0.6 | $1.0M | +8% | 21k | 48.62 |
|
| Anheuser-Busch InBev NV (BUD) | 0.5 | $847k | -41% | 7.1k | 119.30 |
|
| Kellogg Company (K) | 0.5 | $819k | -85% | 13k | 62.50 |
|
| Amicus Therapeutics (FOLD) | 0.5 | $826k | +78% | 150k | 5.49 |
|
| Esperion Therapeutics (ESPR) | 0.5 | $833k | -73% | 17k | 50.08 |
|
| Wal-Mart Stores (WMT) | 0.4 | $782k | NEW | 10k | 78.20 |
|
| Uniqure Nv (QURE) | 0.4 | $686k | -51% | 72k | 9.58 |
|
| Hain Celestial (HAIN) | 0.3 | $629k | -58% | 15k | 41.11 |
|
| Dex (DXCM) | 0.3 | $610k | NEW | 13k | 48.80 |
|
| Juno Therapeutics | 0.3 | $599k | NEW | 13k | 45.00 |
|
| Foot Locker (FL) | 0.3 | $582k | NEW | 17k | 35.25 |
|
| Sarepta Therapeutics (SRPT) | 0.3 | $596k | +76% | 92k | 6.46 |
|
| Tetraphase Pharmaceuticals | 0.3 | $594k | NEW | 87k | 6.83 |
|
| Scynexis | 0.3 | $581k | -3% | 241k | 2.41 |
|
| Fibrocell Science | 0.3 | $484k | NEW | 159k | 3.05 |
|
| Newlink Genetics Corporation | 0.2 | $416k | NEW | 41k | 10.19 |
|
| Bluebird Bio (BLUE) | 0.2 | $405k | NEW | 23k | 17.60 |
|
| Intuitive Surgical (ISRG) | 0.2 | $356k | -55% | 4.5k | 79.00 |
|
| Illumina (ILMN) | 0.2 | $350k | 14k | 24.65 |
|
|
| Mosaic (MOS) | 0.2 | $342k | NEW | 16k | 21.44 |
|
| Hershey Company (HSY) | 0.2 | $329k | +25% | 80k | 4.12 |
|
| Puma Biotechnology (PBYI) | 0.2 | $314k | -69% | 25k | 12.34 |
|
| Dermira | 0.2 | $309k | NEW | 112k | 2.77 |
|
| Avexis | 0.2 | $296k | +104% | 43k | 6.89 |
|
| Mondelez Int (MDLZ) | 0.1 | $271k | -7% | 134k | 2.03 |
|
| Vaneck Vectors Gold Miners mutual (GDX) | 0.1 | $269k | NEW | 12k | 22.90 |
|
| Ggp | 0.1 | $241k | NEW | 12k | 20.49 |
|
| Potash Corp. Of Saskatchewan I | 0.1 | $217k | -91% | 11k | 19.21 |
|
| Teva Pharmaceutical Industries (TEVA) | 0.1 | $171k | NEW | 380k | 0.45 |
|
| Paypal Holdings (PYPL) | 0.1 | $174k | -25% | 30k | 5.80 |
|
| Nabriva Therapeutics | 0.1 | $164k | +32% | 20k | 8.20 |
|
| Alexion Pharmaceuticals | 0.1 | $105k | NEW | 15k | 7.20 |
|
| Cal-Maine Foods (CALM) | 0.1 | $105k | NEW | 45k | 2.33 |
|
| Cytokinetics (CYTK) | 0.1 | $108k | NEW | 36k | 2.99 |
|
| Zynerba Pharmaceuticals | 0.1 | $114k | +400% | 63k | 1.82 |
|
| Ionis Pharmaceuticals (IONS) | 0.1 | $112k | NEW | 104k | 1.07 |
|
| Cascadian Therapeutics | 0.1 | $119k | -6% | 119k | 1.00 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $100k | +13% | 12k | 8.62 |
|
| Firsthand Tech Value (SVVC) | 0.1 | $88k | -45% | 11k | 8.00 |
|
| Chimerix (CMRX) | 0.1 | $99k | +99% | 150k | 0.66 |
|
| Zafgen | 0.1 | $90k | -57% | 26k | 3.51 |
|
| Loxo Oncology | 0.1 | $95k | NEW | 13k | 7.33 |
|
| Axovant Sciences | 0.1 | $95k | +1144% | 528k | 0.18 |
|
| Monsanto Company | 0.0 | $65k | -15% | 21k | 3.04 |
|
| Verizon Communications (VZ) | 0.0 | $77k | +61% | 53k | 1.47 |
|
| Kohl's Corporation (KSS) | 0.0 | $60k | NEW | 18k | 3.43 |
|
| Colgate-Palmolive Company (CL) | 0.0 | $62k | -45% | 61k | 1.02 |
|
| Henry Schein (HSIC) | 0.0 | $61k | NEW | 36k | 1.68 |
|
| Big Lots (BIGGQ) | 0.0 | $52k | NEW | 13k | 3.90 |
|
| Herbalife Ltd Com Stk (HLF) | 0.0 | $47k | NEW | 15k | 3.13 |
|
| Spark Therapeutics | 0.0 | $54k | NEW | 29k | 1.85 |
|
| Inotek Pharmaceuticals | 0.0 | $63k | -87% | 35k | 1.80 |
|
| Zosano Pharma | 0.0 | $49k | 60k | 0.82 |
|
|
| Nordstrom (JWN) | 0.0 | $43k | NEW | 58k | 0.74 |
|
| Rockwell Collins | 0.0 | $44k | NEW | 12k | 3.64 |
|
| United Therapeutics Corporation (UTHR) | 0.0 | $33k | NEW | 11k | 3.08 |
|
| Valeant Pharmaceuticals Int | 0.0 | $40k | -31% | 51k | 0.78 |
|
| EXACT Sciences Corporation (EXAS) | 0.0 | $44k | NEW | 14k | 3.14 |
|
| Metropcs Communications (TMUS) | 0.0 | $34k | NEW | 20k | 1.69 |
|
| Perrigo Company (PRGO) | 0.0 | $29k | NEW | 15k | 1.93 |
|
| Versartis | 0.0 | $31k | NEW | 520k | 0.06 |
|
| Aercap Holdings Nv Ord Cmn (AER) | 0.0 | $16k | NEW | 10k | 1.60 |
|
| Coca-Cola Company (KO) | 0.0 | $17k | -59% | 60k | 0.28 |
|
| Spdr S&p 500 Etf (SPY) | 0.0 | $10k | NEW | 25k | 0.40 |
|
| Kroger (KR) | 0.0 | $15k | +156% | 64k | 0.23 |
|
| Pinnacle Foods Inc De | 0.0 | $18k | 27k | 0.67 |
|
|
| Monster Beverage Corp (MNST) | 0.0 | $10k | NEW | 10k | 1.00 |
|
| Coca Cola European Partners (CCEP) | 0.0 | $19k | 35k | 0.53 |
|
|
| Arena Pharmaceuticals | 0.0 | $14k | NEW | 10k | 1.40 |
|
| Abbott Laboratories (ABT) | 0.0 | $3.0k | -54% | 51k | 0.06 |
|
| Harley-Davidson (HOG) | 0.0 | $3.0k | -12% | 10k | 0.30 |
|
| AstraZeneca (AZN) | 0.0 | $9.0k | -21% | 47k | 0.19 |
|
| Pepsi (PEP) | 0.0 | $7.8k | -52% | 49k | 0.16 |
|
| United Technologies Corporation | 0.0 | $4.1k | NEW | 13k | 0.31 |
|
| Ca | 0.0 | $2.0k | 10k | 0.20 |
|
|
| Rite Aid Corporation | 0.0 | $915.000000 | 31k | 0.03 |
|
|
| Children's Place Retail Stores (PLCE) | 0.0 | $5.8k | NEW | 34k | 0.17 |
|
| Church & Dwight (CHD) | 0.0 | $990.000000 | NEW | 17k | 0.06 |
|
| TransDigm Group Incorporated (TDG) | 0.0 | $5.0k | -31% | 11k | 0.47 |
|
| Otonomy | 0.0 | $6.2k | +39% | 207k | 0.03 |
|
| Dynavax Technologies (DVAX) | 0.0 | $0 | -72% | 51k | 0.00 |
|
| Paratek Pharmaceuticals | 0.0 | $5.4k | NEW | 11k | 0.51 |
|
Past Filings by FT Options
SEC 13F filings are viewable for FT Options going back to 2015
- FT Options 2017 Q3 filed Nov. 13, 2017
- FT Options 2017 Q2 filed Aug. 11, 2017
- FT Options 2017 Q1 filed May 12, 2017
- FT Options 2016 Q4 filed Feb. 10, 2017
- FT Options 2016 Q3 filed Nov. 10, 2016
- FT Options 2016 Q2 filed Aug. 12, 2016
- FT Options 2016 Q1 filed May 9, 2016
- FT Options 2015 Q4 filed Feb. 5, 2016